Oramed’s oral insulin pill fails; stock is down 72%

Shares of Oramed Pharmaceuticals Inc. ORMP, -76.56% plunged 72% in premarket trading on Thursday, the day after the company told investors its oral insulin medication did not meet the primary or secon...

Cramer’s lighting round: Stay away from Blackline

Blackline Inc: “It’s enterprise software that’s losing money. Those are the ones I’m trying to get people to stay away from.” Piedmont Lithium Inc: “Much too danger...